Found: 7
Select item for more details and to access through your institution.
mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2023, v. 483, n. 6, p. 821, doi. 10.1007/s00428-023-03688-2
- By:
- Publication type:
- Article
Deciphering intra-tumor heterogeneity of lung adenocarcinoma confirms that dominant, branching, and private gene mutations occur within individual tumor nodules.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Doing more with less: fluorescence in situ hybridization and gene sequencing assays can be reliably performed on archival stained tumor tissue sections.
- Published in:
- 2016
- By:
- Publication type:
- journal article
AKT1 and BRAF mutations in pediatric aggressive fibromatosis.
- Published in:
- Cancer Medicine, 2016, v. 5, n. 6, p. 1204, doi. 10.1002/cam4.669
- By:
- Publication type:
- Article
A Multi-Center, Real-Life Experience on Liquid Biopsy Practice for EGFR Testing in Non-Small Cell Lung Cancer (NSCLC) Patients.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 10, p. 765, doi. 10.3390/diagnostics10100765
- By:
- Publication type:
- Article
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
First-line tepotinib for a very elderly patient with metastatic NSCLC harboring MET exon 14 skipping mutation and high PD-L1 expression.
- Published in:
- Drug Target Insights, 2023, v. 17, n. 1, p. 110, doi. 10.33393/dti.2023.2626
- By:
- Publication type:
- Article